Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2071250074) titled 'A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis' on Sept. 26.
Study Type: Interventional
Study Design:
randomized controlled trial, double blind, placebo control, parallel assignment, treatment purpose
Primary Sponsor: Kano Yuya
Condition:
Colitis, Ulcerative
Intervention:
Experimental: Double-blind (DB) Induction Study: Icotrokinra
Adult participants will be randomized to receive icotrokinra daily, orally starting at induction Week 0 (Week I-0). At Week I-12, all participants will be evaluated for clinical response and will e...